First Venture Sweden AB Class B
SSTO:FIRST_B1.32
SEK
+0.01
(+0.76%)
ISIN
SE0016075451
Return %
Stock
S&P 500
1Y
-34.89
14.20
3Y
-53.63
81.12
5Y
-81.49
68.34
Capital Structure
SEK
•
in mil. unless spec.Working Capital
SEK
•
in mil. unless spec.Growth Rates
SEK
•
in mil. unless spec.Quarterly Revenue
SEK
•
in mil. unless spec.Quarterly Earnings Per Share
SEK
•
in mil. unless spec.Quarterly Dividends Per Share
SEK
•
in mil. unless spec.Company Description
- CEO
- Andreas Lindenhierta
- Full Time Employees
- 1
- Sector
- Finance
- Industry
- Investment managers
- Address
- Birger Jarlsgatan 37 Stockholm AB Sweden 111 45
- IPO Date
- Jul 2, 2021
- Website
- first-venture.se
- Similar Companies
- Business
- First Venture Sweden AB (publ) is a Stockholm-headquartered investment company founded in 2006, specializing in growth investments in companies within the key megatrends of technology, health, and sustainability. The company invests in both unlisted and listed growth companies, focusing on sectors such as digital technology, health innovation including preventive health measures, and sustainable technology solutions. Its core business activities include providing venture capital, growth capital, and bridge financing with equity investments typically ranging from $0.1 million to $5 million per transaction, targeting companies with enterprise values up to $50 million. First Venture primarily takes minority stakes and supports companies based in Sweden that have global market potential. In recent developments, the company approved a new share issue with preferential rights to shareholders aimed at strengthening its capital base. It has also been involved in strategic portfolio management such as the sale of cancer program TREX1 by Sprint Bioscience, a portfolio company, to Gilead Sciences, reflecting active management and value realization in its investments. First Venture continues to operate as a long-term, active owner with a strategy focused on supporting innovative entrepreneurial teams in scaling their businesses internationally. The company serves markets primarily in Sweden but targets global opportunities through its investment portfolio and emphasizes sustainability, digitalization, and health as driving future growth themes. This description reflects the company's main products and services as a venture capital and private equity investor, along with its latest significant strategic activities including capital increases and portfolio management transactions.